Recent Posts
- Targeted Lysosomal Degradation of Mutant Huntingtin by Engineered Intrabody Peptide SM3
- Researchers Unveil a Novel Strategy for Protein Miniaturization in the CRISPR-Cas System
- Taysha Drops Gene Therapy Candidate as FDA Again Calls for Study Changes
- PackGene Biotech and Kudo Biotechnology Partner to Offer Customized mRNA Manufacturing Services
- FDA Accepts Orchard’s BLA for Rare Disease Gene Therapy Behind EU Approval
AAV One-stop Solution
Tags
AAV1.NT-3
AAV2
AAV5
AAV based gene therapy
AAV Capsid
Alzheimer’s Disease
brain vasculature
CAR-T
CRISPR
CRISPR/Cas
dystrophin
eye disease
gene editing
gene therapy
genetic engineering
genome editing
GMP AAV
GMP plasmid
hearing
heart disease
hemophilia
hepatitis research
HIV
Knee Osteoarthritis
liver cancer
mouse model
mRNA
muscular dystrophy
Parkinson
protein BVES
rare disease
Retinoschisis
RNAi therapeutics
RNA vaccines
sarcopenia
SARS-CoV-2
SMA Treatment
thyroid
zolgensma